NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Dec 2019
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Mechanism of Action
Pharmacologic Class:
Antisense Oligonucleotide
Loss of Exclusivity
LOE Date
Jun 28, 2028
28 months away
Patent Expiry
Jun 28, 2028
Exclusivity Expiry
Dec 12, 2026
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| RE47691 | Jun 28, 2028 | Product | — |